Dr. Ronald Hirsch of R1RCM discusses considerations around a new Alzheimer's drug with Senior Editor Nick Hut.

Mentioned in this episode:
CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS

NCA - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) - Proposed Decision Memo (cms.gov)

Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut

The Healthcare Financial Management Association provides industry insights and in-depth stories about hot topics in healthcare finance. Experts weigh in on the latest in healthcare finance policy and practice, and healthcare insiders discuss the most pressing issues facing the industry. podcast@hfma.org

Business

Investing

Careers

Management & Marketing

Business News

Shopping

News

News Commentary

The cover story in the May issue of hfm focuses on a South Dakota health system that developed a new process to identify charity care patients. In this episode, HFMA Policy Director Shawn Stack discusses why good financial assistance policies and process are essential to patient care.

It's time to revisit your charity care policy

Dr. Vishnukamal Golla discusses the challenges facing primary care physicians and their patients. News team Nick Hut and Shawn Stack provide an update on the Change Healthcare cyberattack and other current events.

Mentioned in this episode:
Multiple GA hospitals accused of not complying with Price Transparency Rule

The "dystopian" state of primary care

The February cyberattack on Change Healthcare, a unit of UnitedHealth Group, continues to cause concern and frustration for providers. In this episode, HFMA Senior Editor Nick Hut and Policy Director Shawn Stack discuss the latest developments, and Joshua Corman, founder of cybersecurity organization I Am the Cavalry, shares insights on what should come next in healthcare.

What the Change Healthcare cyberattack means for the future of the industry

GLP-1 agonists, medications originally formulated to treat diabetes, have gained traction as prescription drugs for weight loss. On this episode, medical researcher and patient advocate Ragen Chastain discusses what healthcare providers should be sharing with their patients about the risks and efficacy of Wegovy and Zepbound.

The hidden risks of weight loss drugs

Chad Mulvany, vice president of federal policy for the California Hospital Association and former HFMA policy director, discusses Bloomberg Philanthropies $250 million investment in the future healthcare workforce, as well as what will actually move the needle on price transparency.

Discussed in this episode:
‘Healthcare High’ coming to Woodside
Northwell, NYC Public Schools announce Northwell School of Health Sciences
The fight for transparency health care prices in America

Healthcare Blame Game: Bloomberg Philanthropies puts $250 million into educating new healthcare workers while Patient Rights Advocate spends on spreading misinformation

Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut

Download our free app to listen on your phone